TransMedics Group, Inc. (TMDX) stock
TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3029% below fair value
$93.91+1.70 (+1.84%)
Close on Nov 17, 2026Market cap $3.26BP/E 24.4Yield 0.00%
TransMedics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
TransMedics's price to book ratio was 6.2× on Nov 11, 2026, against 14.1× a year earlier. Over the last 5 years it ranged from 4.4× to 31.0×, with a median of 13.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 6.2× | −5.5 |
| 2025 | Dec 31, 2025 | 11.7× | +1.7 |
| 2024 | Dec 31, 2024 | 10.0× | −10.4 |
| 2023 | Dec 29, 2023 | 20.4× | +9.9 |
| 2022 | Dec 30, 2022 | 10.5× | +3.7 |
| 2021 | Dec 31, 2021 | 6.8× | +1.8 |
| 2020 | Dec 31, 2020 | 4.9× | +2.2 |
| 2019 | Dec 31, 2019 | 2.8× | – |
See a number that looks wrong?